National Biologics Facility - Queensland Node

The focus of the National Biologics Facility (NBF) is production of high-quality recombinant proteins in pre-clinical or clinical quantities.

The NBF specialises in use of mammalian cell expression technology for proteins with potential therapeutic or commercial uses. The facility was established in 2007 to assist Australian biotechnology companies and academic researchers to bridge the gap between laboratory experiments and the well-characterised cell line and bioprocesses required to produce material at the pilot scale. The NBF has a proven track record in mammalian cell line development and recombinant protein expression and purification at the Queensland node, and various expression systems at the CSIRO's Victoria node.

National Biologics Facility website


The facility offers protein production services from research to pilot scale (0.1-100L) and has dedicated protein purification suites capable of isolating milligrams to grams of protein. In addition, the NBF offers specialist cell line services for the development and optimisation of transient and stable protein expression systems.

The NBF specialises in:

  • Cell line development
  • Antibody engineering
  • Biologics production
  •  Protein analytics.

For more information, email Dr Jeff Hou or Dr Martina Jones at the Queensland node or Prof George Lovrecz at the Victorian node.